CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. [electronic resource]
Producer: 20150413Description: 688-96 p. digitalISSN:- 1592-8721
- Apoptosis -- drug effects
- Ataxia Telangiectasia Mutated Proteins -- antagonists & inhibitors
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Checkpoint Kinase 1
- Dose-Response Relationship, Drug
- Drug Synergism
- Gene Expression Profiling
- Gene Silencing
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Nuclear Proteins -- antagonists & inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Protein Kinases -- genetics
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrazoles -- pharmacology
- Pyrimidines -- pharmacology
- Pyrimidinones
- RNA Interference
- RNA, Small Interfering -- genetics
- Signal Transduction
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.